Travere Therapeutics to Present at the 2024 Cantor Global Healthcare Conference
Travere Therapeutics (NASDAQ: TVTX) has announced its participation in the 2024 Cantor Global Healthcare Conference. The company's management will present on Tuesday, September 17, 2024, at 9:45 a.m. ET. This event provides an opportunity for investors and interested parties to gain insights into Travere's latest developments and strategies.
A live webcast of the presentation will be available on the Investor page of Travere's website at ir.travere.com/events-presentations. For those unable to attend the live event, a replay will be accessible for up to 30 days following the conference. This allows stakeholders to stay informed about Travere's progress and future plans in the healthcare sector.
Travere Therapeutics (NASDAQ: TVTX) ha annunciato la sua partecipazione alla Conferenza Sanitaria Globale Cantor 2024. La gestione dell'azienda presenterà martedì 17 settembre 2024, alle 9:45 ET. Questo evento offre un'opportunità per investitori e parti interessate di conoscere gli ultimi sviluppi e strategie di Travere.
Una webcast dal vivo della presentazione sarà disponibile nella pagina per gli investitori sul sito web di Travere all'indirizzo ir.travere.com/events-presentations. Per coloro che non possono partecipare all'evento dal vivo, una registrazione sarà accessibile per un massimo di 30 giorni dopo la conferenza. Questo consente agli stakeholder di rimanere informati sui progressi e sui piani futuri di Travere nel settore sanitario.
Travere Therapeutics (NASDAQ: TVTX) ha anunciado su participación en la Conferencia Global de Salud Cantor 2024. La dirección de la empresa realizará su presentación el martes 17 de septiembre de 2024, a las 9:45 a.m. ET. Este evento ofrece una oportunidad para que inversores y partes interesadas obtengan información sobre los últimos desarrollos y estrategias de Travere.
Una transmisión en vivo de la presentación estará disponible en la página de Inversores del sitio web de Travere en ir.travere.com/events-presentations. Para aquellos que no puedan asistir al evento en vivo, una repetición estará accesible durante un máximo de 30 días después de la conferencia. Esto permite a los interesados mantenerse informados sobre el progreso y los planes futuros de Travere en el sector de la salud.
Travere Therapeutics (NASDAQ: TVTX)는 2024 캔토 글로벌 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사 경영진은 2024년 9월 17일 화요일 오전 9시 45분 ET에 발표할 예정입니다. 이 행사는 투자자와 이해관계자들이 Travere의 최신 개발 및 전략에 대한 통찰을 얻을 수 있는 기회를 제공합니다.
발표의 실시간 웹캐스트는 Travere 웹사이트의 투자자 페이지에서 ir.travere.com/events-presentations을 통해 제공됩니다. 실시간 행사에 참석할 수 없는 분들을 위해, 컨퍼런스 이후 최대 30일 동안 재생이 가능합니다. 이는 이해관계자들이 Travere의 진행 상황과 향후 계획에 대한 정보를 지속적으로 확인할 수 있게 해줍니다.
Travere Therapeutics (NASDAQ: TVTX) a annoncé sa participation à la Conférence Mondiale sur la Santé Cantor 2024. La direction de l'entreprise fera une présentation le mardi 17 septembre 2024 à 9h45 ET. Cet événement offre une occasion aux investisseurs et aux parties intéressées d'obtenir des informations sur les derniers développements et stratégies de Travere.
Une diffusion en direct de la présentation sera disponible sur la page Investisseurs du site Web de Travere à l'adresse ir.travere.com/events-presentations. Pour ceux qui ne peuvent pas assister à l'événement en direct, une rediffusion sera accessible pendant 30 jours suivant la conférence. Cela permet aux parties prenantes de rester informées des avancées et des projets futurs de Travere dans le secteur de la santé.
Travere Therapeutics (NASDAQ: TVTX) hat seine Teilnahme an der 2024 Cantor Global Healthcare Conference angekündigt. Die Unternehmensführung wird am Dienstag, dem 17. September 2024, um 9:45 Uhr ET präsentieren. Diese Veranstaltung bietet Investoren und Interessierten die Möglichkeit, Einblicke in die neuesten Entwicklungen und Strategien von Travere zu erhalten.
Ein Live-Stream der Präsentation wird auf der Investoren-Seite von Travere's Website unter ir.travere.com/events-presentations verfügbar sein. Für diejenigen, die nicht an der Live-Veranstaltung teilnehmen können, wird eine Wiederholung für bis zu 30 Tage nach der Konferenz zugänglich sein. Dies ermöglicht es den Stakeholdern, über Travere's Fortschritte und Zukunftspläne im Gesundheitswesen informiert zu bleiben.
- None.
- None.
SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that company management will present at the 2024 Cantor Global Healthcare Conference on Tuesday, September 17, 2024, at 9:45 a.m. ET.
A live webcast will be accessible on the Investor page of Travere’s website at ir.travere.com/events-presentations, and a replay will be available for up to 30 days following the event.
About Travere Therapeutics
At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families, and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop, and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com.
Contact:
| Investors: 888-969-7879 IR@travere.com | Media: 888-969-7879 mediarelations@travere.com |
FAQ
When is Travere Therapeutics (TVTX) presenting at the 2024 Cantor Global Healthcare Conference?
How can I watch Travere Therapeutics' (TVTX) presentation at the 2024 Cantor Global Healthcare Conference?
How long will the replay of Travere Therapeutics' (TVTX) 2024 Cantor Global Healthcare Conference presentation be available?
What is the stock symbol for Travere Therapeutics mentioned in the press release?
